Jane Presti
Westfield, NJNPI 1871802140
Payments from drug & device makers
$1,567in general payments, 2019–2025
Across 110 payments — averaging $14.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$287
- GSK$233
- Takeda Pharmaceuticals U.S.A., Inc.$200
- Pfizer$164
- Merck$153
- Cranial Technologies, Inc$121
- plus $408 from 14 others
What the payments were for
- Food & beverage$1,567100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 20 | $287 |
| GSK | 15 | $233 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $200 |
| Pfizer | 12 | $164 |
| Merck | 11 | $153 |
| Cranial Technologies, Inc | 9 | $121 |
| Sanofi Pasteur Inc. | 5 | $74 |
| Alk-abello, Inc | 3 | $53 |
| Arbor Pharmaceuticals, Inc. | 3 | $44 |
| Adlon Therapeutics L.p. | 3 | $39 |
| Genentech USA, Inc. | 3 | $38 |
| Organon | 2 | $31 |
| Tris Pharma Inc | 2 | $29 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Seqirus USA Inc | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Aytu Biopharma, Inc. | 1 | $15 |
| Kaleo, Inc. | 1 | $14 |
| Dermira, Inc. | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.